ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.420
+0.050 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.430
+0.010 (0.70%)
After-hours: Dec 5, 2025, 7:49 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $76.99 million as of December 5, 2025. Its market cap has increased by 19.65% in one year.
Market Cap
76.99M
Enterprise Value
32.24M
1-Year Change
19.65%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $76.99M, a decrease of -92.71%. That is a compound annual growth rate of -38.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 74.28M | -15.67% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |